Back to DANSKE BANK A/S DANSKE BANK A/S

ATHEATHE

8 quarters

Position history for DANSKE BANK A/SDANSKE BANK A/S's holdings in Alterity Therapeutics Ltd

Yes. Danske Bank holds 1 shares of ATHE (Alterity Therapeutics), worth $5, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Danske Bank has held ATHE since Q3 2024, across 8 quarterly 13F filings.

Current Value

$5

Current Shares

1

Total Value Change

+$4

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1
0.0%
$50.0%$5.37
0
2026-Q1
Unchanged
1
0.0%
$40.0%$3.48
0
2025-Q4
Unchanged
1
0.0%
$30.0%$3.08
0
2025-Q3
Unchanged
1
0.0%
$40.0%$3.76
0
2025-Q2
Unchanged
1
0.0%
$40.0%$4.09
0
2025-Q1
Unchanged
1
0.0%
$30.0%$3.45
0
2024-Q4
Unchanged
1
0.0%
$30.0%$3.31
0
2024-Q3
New
1
—
$10.0%$1.31
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used